论文部分内容阅读
目的:了解我州药品不良反应/事件(ADR/ADE)发生情况。方法:汇总我州2010年ADR/ADE报告进行统计分析。结果:药品零售企业、医疗机构及诊所为两大主要报告来源;244例ADR/ADE中口服给药占52.87%,静脉滴注占40.57%;抗感染药居首位,其次是中药注射剂;ADR/ADE的临床表现形式呈多样性,以过敏反应比较多见。结论:必须加强ADR/ADE监测、报告、防范和处理,强化临床用药安全保障,有效减少ADR/ADE重复发生。
Objective: To understand the incidence of adverse drug reactions / events (ADR / ADE) in our state. Methods: I summarize the 2010 ADR / ADE report for statistical analysis. Results: Drug retail enterprises, medical institutions and clinics were the two major sources of reports. In 244 ADRs / ADEs, oral administration accounted for 52.87% and intravenous drip accounted for 40.57%. Anti-infectives ranked first, followed by Chinese injection. ADR / ADE showed a variety of clinical manifestations to allergic reactions more common. Conclusion: ADR / ADE monitoring, reporting, prevention and treatment must be strengthened to enhance the safety of clinical medication and reduce the recurrence of ADR / ADE effectively.